BioLineRx Ltd. Cash And Cash Equivalents
BioLineRx Ltd. (BLRX) had Cash And Cash Equivalents of $3.25 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-23
- 2025-12-31: Cash And Cash Equivalents $3.25M.
- 2025-06-30: Cash And Cash Equivalents $7.19M.
- 2024-12-31: Cash And Cash Equivalents $10.44M.
- 2024-06-30: Cash And Cash Equivalents $9.62M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $3.25M 20-F · filed 2026-03-23 |
| 2025-06-30 | $7.19M 6-K · filed 2025-08-14 |
| 2024-12-31 | $10.44M 20-F · filed 2026-03-23 |
| 2024-06-30 | $9.62M 6-K · filed 2025-08-14 |
| 2023-12-31 | $4.25M 20-F · filed 2026-03-23 |
| 2023-06-30 | $10.10M 6-K · filed 2024-08-15 |
| 2022-12-31 | $10.59M 20-F · filed 2026-03-23 |
| 2022-06-30 | $14.00M 6-K · filed 2023-08-30 |
| 2021-12-31 | $12.99M 20-F · filed 2025-03-31 |
| 2021-06-30 | $17.48M 6-K · filed 2022-08-16 |
| 2020-12-31 | $16.83M 20-F · filed 2024-03-26 |
| 2020-06-30 | $5.52M 6-K · filed 2021-08-18 |
| 2019-12-31 | $5.30M 20-F · filed 2023-03-22 |
| 2019-06-30 | $4.97M 6-K · filed 2020-08-06 |
| 2018-12-31 | $3.40M 20-F · filed 2022-03-16 |
| 2018-06-30 | $5.79M 6-K · filed 2019-08-06 |
| 2017-12-31 | $5.11M 20-F · filed 2021-02-23 |
| 2017-06-30 | $6.95M 6-K · filed 2018-08-13 |
| 2016-12-31 | $2.47M 20-F · filed 2020-03-12 |
| 2015-12-31 | $5.54M 20-F · filed 2019-03-28 |
| 2014-12-31 | $5.79M 20-F · filed 2018-03-06 |